scholarly journals Proprioceptive activities to postural balance of the elderly - systematic review

2018 ◽  
Vol 31 (0) ◽  
Author(s):  
Adriano Drummond ◽  
Clarissa Cardoso dos Santos Couto Paz ◽  
Ruth Losada de Menezes

Abstract Introduction: Proprioceptive activities are commonly described for control of the postural balance of the elderly in order to avoid falls. But, there is no consensus on which ones can significantly improve balance or on intervention and assessment protocols. Objective: To investigate which proprioceptive activities are specific to static and dynamic postural balance of the elderly through a systematic review. Method: This is a systematic review based on PRISMA recommendation, by surveying PubMed, Medline, LILACS, Scielo and EBSCO databases. The period considered for the search was from 2006 to 2016, using the following descriptors - aged, proprioception, exercise therapy, and postural balance for articles in English, Portuguese or Spanish. Randomized and non-randomized clinical trials were included using the PEDro scale to analyze the methodological quality of the studies. Results: Eight articles were included with different protocols, without standardization of evaluation and intervention, but, which demonstrated improvement of functional abilities. Different kinds of walk, muscular strengthening exercises, stretching, postural oscillations and Yoga patterns for the improvement of functional abilities. Conclusion: The association of static and dynamic activities can contribute to the improvement of functional abilities, but it cannot be affirmed that they are specific for postural control, given the lack of standardization of exercise protocols and evaluation tools.

2019 ◽  
Vol 2019 ◽  
pp. 1-18
Author(s):  
Jing Guo ◽  
Bin Li ◽  
Wenbin Wu ◽  
Zhichao Wang ◽  
Fei Wang ◽  
...  

Background. Idiopathic pulmonary fibrosis (IPF) is a major global health problem. The prevalence of the disease appears to be increasing. There is no curative therapy for IPF except lung transplantation. Chinese herbal medicines (CHMs) are showing promise for treatment of IPF. However, their effectiveness and safety are still unclear and deserve further investigation. The aim of this systematic review is to access the efficacy and safety of CHMs in treating IPF. Methods. The protocol of this review is registered at PROSPERO. We searched seven main databases for randomized clinical trials (RCTs) on CHMs for IPF from their inception to June 4, 2018. The methodological quality of RCTs was assessed using the Cochrane risk of bias tool. All trials included were analyzed according to the criteria of the Cochrane Handbook. Review Manager 5.3, R-3.5.2 software, and Grade pro GDT web solution were used for data synthesis and analysis. Results. Thirteen randomized clinical trials enrolling 733 patients were included. All trials included had clear outcome indicators. The methodological quality of included trials was generally “poor.” Few trials reported methods of randomization. One trial on Xuefu-zhuyu capsule assessed rate of acute exacerbation and mortality after treatment for 72 weeks and found no statistically significant difference between two groups. This meta-analysis demonstrated a significant improvement in QOL of IPF patients when CHMs was applied or combined with conventional medicine treatment. 6MWT was significantly improved in IPF patients after using CHMs or combined with conventional medicine treatment. CHMs treatment also had a certain improvement in TLC and DLCO, but the effect on FVC was not significant. Besides, CHMs failed to provide benefits in terms of PaO2. The reported adverse events were not obvious and severe. Conclusions. Some CHMs seem effective and safe as alternative remedies for patients with IPF, suggesting that further study of CHMs in the treatment of IPF is warranted. Although this systematic review suggests that CHMs may have positive effect on quality of life, 6-minute walk test distance, and lung function (TLC, DLOC%) and seem to be relatively safe during the course of treatment, the results must be treated with great caution because of the methodological flaws of the included trials. Long-term and high-quality trials are needed in the future to provide clear evidence for the use of CHMs.


2018 ◽  
Vol 8 (4) ◽  
pp. 551-557
Author(s):  
Priscila Silva Costa ◽  
Elaine Cristina Cartaxo Villas Bôas ◽  
Erika Pedreira da Fonseca

INTRODUCTION: Hydrotherapy is increasingly used in the treatment of patients with neurodegenerative disease, being aimed at improving functionality and reduce falls. Allows safe walking, promotes relaxation and reduces fear of falling. There is a requirement to analyze the methodological quality of existing studies in this context. OBJECTIVE: To systematize the knowledge about the effectiveness of water walking training for people with Parkinson's disease. METHODS: This is a systematic review. We searched the Pubmed and Lilacs database from March 2017 to May 2018 without filters. We included randomized clinical trials that verified the effects of a water gait training protocol for patients with Parkinson's disease. We excluded studies that performed water training, but not specifically gait. A Cochrane Collaboration tool was utilized to evaluate the methodological quality of the studies. RESULTS: Fifteen studies were found in the search, three of these were included. There was different from those between the articles regarding outcomes, in relation to the increase in walking speed. The methodological quality analysis showed randomization and blindness failure in the methodology of the studies. CONCLUSION: It was evidenced that gait training in water has a positive effect on gait velocity and the mobility of these individuals. For a positive clinical outcome in walking, exercises for mobility and balance should be associated. Further randomized clinical trials are necessary for follow the guidelines and have satisfactory methodological quality.


2019 ◽  
Vol 16 (10) ◽  
pp. 919-933 ◽  
Author(s):  
Alicia Ruiz-Muelle ◽  
María Mar López-Rodríguez

Background: In recent years, several reviews have addressed the effectiveness of dance therapy in dementia, healthy older adults, or the elderly in general. However, reviews regarding the effect of this therapy exclusively on patients diagnosed with Alzheimer’s disease have not been found. Objective: The purpose of this study is to review the available literature describing clinical trials which explore the effects of dancing on psychological and physical outcomes, functionality, cognitive function, and quality of life in patients diagnosed with Alzheimer’s disease. In addition, this review aims to assess the quality of studies that perform dance therapy interventions in these patients. Methods: This study is a systematic review of randomized and non-randomized clinical trials regarding the effect of intervention including a dancing activity in people diagnosed with Alzheimer's disease. Results: In total, the evidence for this review rests on 12 studies with a total of 349 participants. The findings of this mini-review confirm the positive effect of dance therapy on physical and cognitive function, functionality, psychological outcomes, and quality of life in people with Alzheimer's disease. Conclusion: Most of the studies implementing dance as part of the therapeutic treatment has shown to improve or slow the worsening in the quality of life of patients with Alzheimer's disease and their caregivers. Future research focused on these patients should use a more exhaustive methodology and make a more detailed description of these kind of interventions.


2018 ◽  
Vol 9 (1) ◽  
pp. e12290 ◽  
Author(s):  
Alejandro Szmulewicz ◽  
Kerollos N. Wanis ◽  
Ashley Gripper ◽  
Federico Angriman ◽  
Jeff Hawel ◽  
...  

Author(s):  
Nishitha Gopal Rao ◽  
Hai Xia Jing ◽  
Ahmed Raihan Kabir ◽  
Rohit Surthi

<p class="abstract">Chronic spontaneous urticaria (CSU) is a mast cell-driven skin disease characterized by the recurrence of transient wheals, angioedema or both lasting for more than 6 weeks duration. Omalizumab is a newer humanized anti IgE immunoglobulin along with many new antibody treatments has shown beneficial effect in treatment of chronic spontaneous urticaria. Although many randomized clinical trials have been conducted, as of now, the effectiveness of omalizumab in the real world management of CSU is largely unknown. A systematic review of all studies should be done. The objective was to study the efficacy and safety of different doses of omalizumab in the treatment of chronic spontaneous urticaria which was refractory to treatment with H1 antihistamines. Suitable studies were recognized after searching Wiley online library, PubMed, Google scholar, NEJM/NEJ dermatology, JAAD, JACI, clinicaltrials.gov. Only randomized, double-blind, placebo-controlled clinical trials with omalizumab versus antihistamine or leukotriene antagonists as placebo were involved in this study. 10 randomized, placebo-controlled studies were involved with 1692 patients with CSU. Patients treated with omalizumab (75-600 mg every 4 weeks) had reduced UAS7 score, improved QoL (quality of life), reduced WISS, when compared to the placebo group. The effects of omalizumab were found to be dose dependent, with maximum reduction in UAS7 at a dose of 300 mg when given at an interval of 4 weeks’ duration. The incidences of adverse events were almost similar in both control and placebo groups and across various dose ranges. The best effect in reduction of clinical symptoms and QoL in CSU patients was found at a dose of 300 mg subcutaneous injection once a month of omalizumab for 12 to 24 weeks. Omalizumab was found to reduce the clinical symptoms and signs in patients with CSU who were symptomatic despite treatment with upscaling dose of H1 antihistamines.</p>


2021 ◽  
Vol 20 (1) ◽  
pp. 36-45
Author(s):  
Bruno B. Monteiro-Oliveira ◽  
Ana Carolina Coelho-Oliveira ◽  
Tatiane S. A. David ◽  
Adriana T. Brito ◽  
Ana Carla A. Cruz ◽  
...  

Introducton: Chemotherapy is an important therapy in the treatment of cancer. Nausea, vomiting and worsening quality are some adverse effects of chemotherapy. Aromatherapy is an ancient technique that uses essential oils for physical and psychological/emotional improvement and is able to reduce the symptoms of chemotherapy and can be an excellent complementary technique.Objective: The aim of this systematic review was to determine the effects of aromatherapy on the adverse effects of chemotherapy in patients diagnosed with cancer. Methods: A search in three database PubMed, EMBASE and SCOPUS. Five studies that analyzed the use of aromatherapy to evaluate the reduction of the adverse effects of chemotherapy in a cancer patient, published only in English were included. Two reviewers, which independently examined titles and abstracts, identified records through database search and reference screening and irrelevant studies were excluded based in eligibility criteria. Relevant full texts were analyzed for eligibility, and all selected studies were included in this systematic review.  Results: Five studies were included in this systematic review. This review suggests that aromatherapy reduces nausea, frequency of vomiting and improves quality of sleep. Conclusion: Aromatherapy is an effective technique to reduce nausea, the frequency of vomiting and improves the quality of sleep of patients diagnosed with cancer and undergoing chemotherapy. However, more randomized clinical trials with a good methodological quality are necessary to confirm the preliminary findings of this systematic review. 


Sign in / Sign up

Export Citation Format

Share Document